|
|
EQSAdhoc: aap Implantate AG / Key words: Capital Increase
aap Implantate AG resolves on capital increase with subscription rights to strengthen its financial base
21Feb2023 / 12:48 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted by EQS News a service of EQS Group AG.
The issuer is solely responsible for... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: aap Implantate AG
/ Key words: Study
Antibacterial silver coating technology: acceleration of human clinical trial through successfully implemented clinical trial protocol changes
25.11.2022 / 16:27 CET/CEST
The issuer is solely responsible for the content of this announcement.
aap Implantate AG... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: aap Implantate AG
/ Key words: Quarter Results/9 Month figures
Q3/2022: Again significant growth in the US 45 % with sales of EUR 1.0 million; total sales and EBITDA impacted by continued volatile market environment
16.11.2022 / 13:25 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
EQSNews: aap Implantate AG
/ Key words: Preliminary Results/Development of Sales
Q3/2022: Solid third quarter with slight sales growth in persistently volatile market environment; US business back on track with significant 45 % sales increase
25.10.2022 / 07:45 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
DGAPAdhoc: aap Implantate AG / Key words: Capital Increase
aap launches partnership with strategic investor from the Asian region and resolves on capital increase of around 10 %
05Sep2022 / 12:21 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted by DGAP a service of EQS Group AG.
The issuer is solely resp... Lire le communiqué |
|
| |
|
| |
|
|
DGAPNews: aap Implantate AG
/ Key words: Quarter Results
Q2/2022: Sales of EUR 2.7 million and EBITDA of EUR 0.2 million below expectations in persistently challenging macroeconomic environment; growth expected for second half of 2022
12.08.2022 / 07:45 CET/CEST
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
| |
|
| |
|
|
DGAPAdhoc: aap Implantate AG / Key words: Change in Forecast/Quarter Results
aap Implantate AG: Q2 weaker than expected and adjustment of guidance for the financial year 2022 due to increased macroeconomic uncertainties in H2
28Jul2022 / 17:29 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation EU No 596/2014, transmitted by DGAP a service of... Lire le communiqué |
|
| |
|
| |
